Protara Therapeutics (TARA) Short-Term Debt issuances (2020)
Protara Therapeutics (TARA) posted quarterly Short-Term Debt issuances of $3.0 million for Q4 2020, up 632.68% quarter-over-quarter from -$557000.0 in Q3 2020.
Powered by 
Analysis
Protara Therapeutics (TARA) Short-Term Debt issuances (2020) Analysis & Trends
Protara Therapeutics (TARA) has reported Short-Term Debt issuances for 1 consecutive years, with $3.0 million the latest figure, recorded in Q4 2020.
- In Q4 2020, Short-Term Debt issuances changed N/A year-over-year to $3.0 million; the TTM figure through Dec 2020 stood at $1.7 million (changed N/A YoY), while the FY2020 annual figure was $1.7 million, changed N/A from the prior year.
- Short-Term Debt issuances rose to $3.0 million in Q4 2020 per TARA's latest filing, from -$557000.0 in the prior quarter.
- Across five years, Short-Term Debt issuances topped out at $3.0 million in Q4 2020 and bottomed at -$557000.0 in Q3 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Protara Therapeutics | 241.28 Mn | 241.28 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 2.97 Mn |
| Sep 30, 2020 | -557,000.00 |
| Jun 30, 2020 | -371,000.00 |
| Mar 31, 2020 | -370,000.00 |